Course of bipolar illness worsens after onset of insulin resistance

Journal of Psychiatric Research

Volumn 102, Issue , 2018, Pages 34-37

  Cairns, Kathleen ^a   McCarvill, Terrence ^b,c   Ruzickova, Martina ^b   Calkin, Cynthia V ^b  

^a NOVA SCOTIA HEALTH AUTHORITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c Operational Trauma Stress Support Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MORBIDITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; YOUNG ADULT; AGED; CROSS-SECTIONAL STUDY; DISEASE EXACERBATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MORBIDITY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 85044099229     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2018.03.006     Document Type: Article

References (34)

1. Banks, W.A., Owen, J.B., Erickson, M.A., Insulin in the brain: there and back again. Pharmacol. Ther. 136 (2012), 82–93.
2. Calkin, C., Ruzickova, M., Slaney, C., Garnham, J., Uher, R., O'Donovan, C., Alda, M., Insulin resistance: an occult, modifiable risk factor for bipolar disorder?. Int. J. Neuropsychopharmacol. 17 (2014), 52–53.
3. Calkin, C., Van de Velde, C., Ruzickova, M., Slaney, C., Garnham, J., Hajek, T., O'Donovan, C., Alda, M., Can body mass index help predict outcome in patients with bipolar disorder?. Bipolar Disord. 11 (2009), 650–656.
4. Calkin, C.V., Ruzickova, M., Uher, R., Hajek, T., Slaney, C.M., Garnham, J.S., O'Donovan, M.C., Alda, M., Insulin resistance and outcome in bipolar disorder. Br. J. Psychiatry 206 (2015), 52–57, 10.1192/bjp.bp.114.152850.
5. Calkin, C.V., Alda, M., Insulin resistance in bipolar disorder: relevance to routine clinical care. Bipolar Disord. 17 (2015), 683–688, 10.1111/bdi.12330.
6. Calkin, C.V., Gardner, D.M., Ransom, T., Alda, M., The relationship between bipolar disorder and type 2 diabetes: more than just co-morbid disorders. Ann. Med. 45 (2013), 171–181.
7. Coppen, A., Abou-Saleh, M.T., Plasma folate and affective morbidity during long-term lithium therapy. Br. J. Psychiatry 141 (1982), 87–89.
8. Craft, S., Watson, G.S., Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol. 3 (2004), 169–178.
9. Denicoff, K.D., Leverich, G.S., Nolen, W.A., Rush, A.J., McElroy, S.L., Keck, P.E., Suppes, T., Altshuler, L.L., Kupka, R., Frye, M.A., Hatef, J., Brotman, M.A., Post, R.M., Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness. Psychol. Med. 30 (2000), 1391–1397.
10. Denicoff, K.D., Smith-Jackson, E.E., Disney, E.R., Ali, S.O., Leverich, G.S., Post, R.M., Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J. Clin. Psychiatr. 58 (1997), 470–478.
11. Dhananjayan, R., Koundinya, K.S., Malati, T., Kutala, V.K., Endothelial dysfunction in type 2 diabetes mellitus. Indian J. Clin. Biochem. 31 (2016), 372–379.
12. Endicott, J., Spitzer, R.L., A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch. Gen. Psychiatr. 35 (1978), 837–844.
13. Esteghamati, A., Ashraf, H., Khalilzadeh, O., Zandieh, A., Nakhjavani, M., Rashidi, A., Haghazali, M., Asgari, F., Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr. Metab. (Lond), 7, 2010, 26.
14. Frank, H.J., Pardridge, W.M., Jankovic-Vokes, T., Vinters, H.V., Morris, W.L., Insulin binding to the blood-brain barrier in the streptozotocin diabetic rat. J. Neurochem. 47 (1986), 405–411.
15. Goldstein, B.I., Liu, S.-M., Schaffer, A., Sala, R., Blanco, C., Obesity and the three-year longitudinal course of bipolar disorder. Bipolar Disord. 15 (2013), 284–293, 10.1111/bdi.12035.
16. Hajek, T., Calkin, C., Blagdon, R., Slaney, C., Alda, M., Type 2 diabetes mellitus: a potentially modifiable risk factor for neurochemical brain changes in bipolar disorders. Biol. Psychiatr. 77 (2015), 295–303, 10.1016/j.biopsych.2013.11.007.
17. Hajek, T., Calkin, C., Blagdon, R., Slaney, C., Uher, R., Alda, M., Insulin resistance, diabetes mellitus, and brain structure in bipolar disorders. Neuropsychopharmacology 39 (2014), 2910–2918, 10.1038/npp.2014.148.
18. Heni, M., Schöpfer, P., Peter, A., Sartorius, T., Fritsche, A., Synofzik, M., Häring, H.-U., Maetzler, W., Hennige, A.M., Evidence for altered transport of insulin across the blood–brain barrier in insulin-resistant humans. Acta Diabetol. 51 (2014), 679–681.
19. Henneman, D.H., Altschule, M.D., Goncz, R.M., Carbohydrate metabolism in brain disease. II. Glucose metabolism in Schizophrenic, manic-depressive, and involutional psychoses. AMA Arch. Intern. Med 94 (1954), 402–416.
20. Hsueh, W.A., Lyon, C.J., Quinones, M.J., Insulin resistance and the endothelium. Am. J. Med. 117 (2004), 109–117.
21. Jansson, P.A., Endothelial dysfunction in insulin resistance and type 2 diabetes. J. Intern. Med. 262 (2007), 173–183.
22. Kullmann, S., Heni, M., Hallschmid, M., Fritsche, A., Preissl, H., Häring, H.-U., Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans. Physiol. Rev. 96 (2016), 1169–1209, 10.1152/physrev.00032.2015.
23. Mansur, R.B., Rizzo, L.B., Santos, C.M., Asevedo, E., Cunha, G.R., Noto, M.N., Pedrini, M., Zeni, M., Cordeiro, Q., Mcintyre, R.S., Brietzke, E., Impaired glucose metabolism moderates the course of illness in bipolar disorder. J. Affect. Disord. 195 (2016), 57–62, 10.1016/j.jad.2016.02.002.
24. Pardridge, W.M., Blood-brain barrier Carrier-mediated transport and brain metabolism of amino acids. Neurochem. Res. 23 (1998), 635–644.
25. Patel, J.P., Frey, B.N., Disruption in the blood-brain barrier: the missing link between brain and body inflammation in bipolar disorder?. Neural Plast., 2015, 2015.
26. Prasad, S., Sajja, R.K., Naik, P., Cucullo, L., Diabetes mellitus and blood-brain barrier dysfunction: an overview. J. Pharmacovigil, 2, 2014, 10.4172/2329-6887.1000125.
27. Raghavan, V.A., Insulin resistance and atherosclerosis. Heart Fail. Clin. 8 (2012), 575–587.
28. Rask-Madsen, C., King, G.L., Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes. Nat. Clin. Pract. Endocrinol. Metabol. 3 (2007), 46–56.
29. Regenold, W.T., Thapar, R.K., Marano, C., Gavirneni, S., Kondapavuluru, P.V., Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J. Affect. Disord. 70 (2002), 19–26.
30. Roberts, A.C., Porter, K.E., Cellular and molecular mechanisms of endothelial dysfunction in diabetes. Diabetes Vasc. Dis. Res. 10 (2013), 472–482.
31. Ruzickova, M., Slaney, C., Garnham, J., Alda, M., Clinical features of bipolar disorder with and without comorbid diabetes mellitus. Can. J. Psychiatr. 48 (2003), 458–461.
32. Serlin, Y., Levy, J., Shalev, H., Vascular pathology and blood-brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus. Cardiovasc. Psychiatry Neurol 2011 (2011), 1–10, 10.1155/2011/609202.
33. Serlin, Y., Shelef, I., Knyazer, B., Friedman, A., Anatomy and physiology of the blood-brain barrier. Semin. Cell Dev. Biol. 38 (2015), 2–6.
34. Shoelson, S.E., Lee, J., Goldfine, A.B., Inflammation and insulin resistance. J. Clin. Invest. 116 (2006), 1793–1801, 10.1172/JCI29069.